CLINICAL_TRIALS
research
· 2017-01-31
Clinical Trial Update: Minimum Oxytocin Dose for Cesarean During Labor: Adaptative Clinical Trial [Phase 3]
Summary
An adaptive Phase 3 clinical trial update evaluating the minimum oxytocin dose needed for cesarean delivery during labor.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brasilia University Hospital | Conditions: Cesarean Section During Labor | Phase 3 | Status: UNKNOWN